![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Agape ATP Corporation (PK) | USOTC:AATP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.00 | 7.00 | 23.00 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2022
AGAPE ATP CORPORATION
(Exact name of Registrant as specified in its charter)
Nevada | 36-4838886 | |
(State or other jurisdiction | (IRS Employer | |
of incorporation) | Identification No.) |
1705
– 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,
Taman Desa, Kuala Lumpur, Malaysia (Postal Code: 58100).
(Address of principal executive offices, including zip code)
Registrant’s phone number, including area code
+(60) 192230099
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12) | |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, par value $0.0001 | AATP | OTC Markets – Pink Sheets |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
Forfeiture of Common Stock
On March 1, 2022, Agape ATP Corporation (the “Company”) filed a Current Report on From 8-K (the “Original Form 8-K”) disclosing that, on February 28, 2022, there was a closing of a share forfeiture agreement (the “Share Forfeiture Agreement”) dated February 14, 2022, between the Company and Mr. How Kok Choong, pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035 shares of common stock of the Company.
This Current Report on Form 8-K/A hereby amends Item 8.01 of the Original Form 8-K to disclose that the cancelation of 215,008,035 shares (the “Shares”) by Mr. How Kok Choong pursuant to a share forfeiture agreement dated January 20, 2022 (the “Share Forfeiture Agreement”) occurred on January 20, 2022, and the cancelation of the Shares was completed on February 28, 2022.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 7, 2022 | AGAPE ATP CORPORATION | |
By: | /s/ How Kok Choong | |
Name: | How Kok Choong | |
Title: | Chief Executive Officer, Chief Operating Officer President, Director, Secretary and Treasurer |
3 |
1 Year Agape ATP (PK) Chart |
1 Month Agape ATP (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions